Achievable logoAchievable logo
PTCE
Sign in
Sign up
Purchase
Textbook
Practice exams
Support
How it works
Resources
Exam catalog
Mountain with a flag at the peak
Textbook
Introduction
1. Medications
2. Patient safety and quality assurance
3. Order entry and processing
4. Federal requirements
Wrapping up
Achievable logoAchievable logo
1.5.7.6 Antiepileptics, antipsychotics, and lithium
Achievable PTCE
1. Medications
1.5. Medications by organ system
1.5.7. Drugs of the nervous system

Antiepileptics, antipsychotics, and lithium

6 min read
Font
Discuss
Share
Feedback

Antiepileptics

Antiepileptics are drugs used to prevent and treat seizures by reducing abnormal electrical activity in the brain. You may also see them called anticonvulsants or AEDs.

Epilepsy is a chronic disorder marked by recurring seizures. A seizure happens when electrical activity in the brain becomes dysregulated. This abnormal activity can be:

  • Localized (focal)
  • Generalized

AEDs help regulate and stop disorderly electrical activity by acting on ion channels, including:

  • Sodium channels
  • GABA-mediated chloride channels
  • Calcium channels

Some AEDs also block glutamate-mediated electrical currents. Most AEDs affect more than one target.

Several AEDs are strong sodium channel blockers, including:

  • Phenytoin
  • Topiramate
  • Zonisamide
  • Valproic acid
  • Lamotrigine
  • Carbamazepine

Some benzodiazepines (for example, clonazepam) have strong GABA-related activity. Ethosuximide primarily blocks calcium channels.

Some antiepileptics (such as gabapentin, pregabalin, and carbamazepine) are also used to treat neuropathic pain.

Commonly prescribed antiepileptics and their brand names are listed below:

  • Carbamazepine - Tegretol, Epitol
  • Levetiracetam - Keppra, Roweepra
  • Lamotrigine - Lamictal
  • Ethosuximide - Zarontin
  • Phenytoin - Dilantin, Phenytek
  • Fosphenytoin - Cerebyx
  • Felbamate - Felbatol
  • Topiramate - Topamax, Topiragen
  • Valproate or valproic acid or divalproex sodium - Depakote, Depakene, Stavzor, Depacon
  • Gabapentin - Gralise, Horizant, Neurontin
  • Pregabalin - Lyrica
  • Vigabatrin - Sabril
  • Tiagabine - Gabitril
  • Clonazepam - Klonopin
  • Oxcarbazepine - Trileptal
  • Zonisamide - Zonegran
  • Primidone - Mysoline
  • Lacosamide - Vimpat

Antiepileptics are frequently associated with adverse effects, which can make long-term adherence difficult. Common adverse effects include:

  • Drowsiness
  • Rash
  • Diarrhea
  • Disruption of menstrual cycles
  • Infertility
  • Sexual dysfunction
  • Teratogenicity
  • Cognitive issues
  • Restlessness

Weight effects vary by drug:

  • Weight gain: valproic acid, gabapentin, carbamazepine, pregabalin
  • Weight loss: topiramate, zonisamide, felbamate

Other important risks include increased suicidal tendencies, changes in blood counts, and severe allergic reactions.

Notable drug-specific adverse effects include:

  • Phenytoin: gum hyperplasia (overgrowth) and hirsutism
  • Valproate: highest risk of congenital defects in newborn children
  • Vigabatrin: vision problems
  • Lamotrigine (and carbamazepine): serious skin rashes, including Stevens-Johnson syndrome
  • Carbamazepine, phenytoin, and barbiturates: metabolic disturbances such as vitamin D deficiency and dyslipidemias
  • Felbamate and valproate: liver dysfunction

Lithium

Lithium is sold as generic lithium carbonate and under the brand name Lithobid. It is used to treat bipolar disorder and some cases of schizophrenia.

Bipolar disorder is a mood disorder characterized by episodes of mania followed by episodes of depression. Lithium is a mood stabilizer that can help control manic symptoms.

Lithium’s exact mechanism isn’t fully understood, but it’s thought to balance neurotransmitters such as GABA and dopamine, reduce oxidative stress, and inhibit the enzyme glycogen synthase kinase, producing an overall neuroprotective effect.

Adverse effects include restlessness, tremors, bloating, weight changes, rash, and hair loss.

Lithium excess can cause toxicity. Early or mild toxicity may include:

  • Nausea and vomiting
  • Diarrhea
  • Abdominal pain
  • Coarse tremor

Severe toxicity may include:

  • Confusion or delirium
  • Imbalance (ataxia)
  • Slurred speech
  • Seizures
  • Coma

Chronic toxicity may cause kidney damage called nephrogenic diabetes insipidus, which can lead to excessive urination, thirst, and dehydration. Lithium may also cause thyroid dysfunction.

Lithium has a narrow therapeutic index, so blood levels must be monitored regularly.

Antipsychotics

Antipsychotics are medications used to treat psychosis, which can occur in disorders such as schizophrenia, bipolar disorder (mania), and drug-induced psychosis. Many atypical antipsychotics are also approved specifically for treating bipolar disorder.

Based on their activity at neurotransmitter receptors, antipsychotics are classified as:

  • Typical (first-generation)
  • Atypical (second-generation)

Atypical antipsychotics have a lower risk of movement disorders and better effect on negative symptoms, but carry a higher risk of metabolic syndrome.

Typical or conventional or first-generation antipsychotics: These drugs act primarily by blocking D2 dopamine receptors. They include chlorpromazine, thioridazine (Mellaril), trifluoperazine, haloperidol (Haldol), fluphenazine, loxapine (Adasuve), prochlorperazine (Compro), molindone, perphenazine, thiothixene and pimozide (Orap).

Long-acting intramuscular (decanoate) formulations are available for haloperidol and fluphenazine. Long-acting forms are especially useful when compliance is a problem.

Typical antipsychotics can control positive symptoms of schizophrenia but are not useful for treating negative symptoms.

  • Positive symptoms: hallucinations, delusions, paranoia, etc.
  • Negative symptoms: lack of emotions, decreased speech, decreased drive, etc.

Adverse effects of typical antipsychotics include sedation, dry mouth, constipation, low blood pressure, cognitive defects, dystonia, muscle stiffness, tremors, galactorrhea and elevated prolactin levels, seizures, movement disorders, and metabolic syndrome (less likely).

Some drugs have notable eye-related effects:

  • Thioridazine may cause retinal deposits
  • Chlorpromazine may cause corneal deposits

Movement disorders can be incapacitating and may lead to drug non-compliance. These include acute dystonia, akinesia, bradykinesia, akathisia, and tardive dyskinesia.

Atypical or second-generation antipsychotics: These drugs act as weaker D2 blockers than typical antipsychotics, while also blocking serotonin 5HT2A receptors. They are effective in treating both positive and negative symptoms of schizophrenia.

They include clozapine (Clozaril, Versacloz), olanzapine (Zyprexa, Symbyax, Lybalvi), aripiprazole (Abilify, Aristada), asenapine (Saphris, Secuado), brexpiprazole (Rexulti), cariprazine (Vraylar), ziprasidone (Geodon), risperidone (Perseris, Risperdal), lurasidone (Latuda), quetiapine (Seroquel) etc.

Second-generation drugs are preferred because they have a low risk of extrapyramidal effects (movement disorders). However, they are associated with higher mortality in older patients with dementia.

Key points about specific agents:

  • Clozapine is notable for high efficacy.
  • Aripiprazole, olanzapine, and risperidone are available in long-acting injectable formulations.

Adverse effects of clozapine include sedation, hypotension, tachycardia, weight gain, metabolic syndrome, glucose intolerance, and rare but potentially fatal agranulocytosis. Agranulocytosis is severe neutropenia. The absolute neutrophil count (ANC) is monitored regularly during clozapine therapy.

Major adverse effects of second-generation drugs include metabolic syndrome, weight gain, and dyslipidemias. Blood glucose and lipid levels should be monitored.

Next-generation antipsychotics: Xanomeline and trospium combination sold as COBENFY were FDA-approved in 2024. Rather than blocking dopamine receptors, they work by modulating muscarinic (M) receptors in the brain: xanomeline stimulates muscarinic (M1/M4) receptors in the brain, while trospium blocks muscarinic receptors outside the brain to limit side effects such as nausea.

Adverse effects include urinary retention, liver dysfunction, jaundice, glaucoma, angioedema, fast heart rate, constipation, nausea, dizziness, and hypertension.

Antipsychotics that may prolong QTc: They include thioridazine, haloperidol, olanzapine, risperidone, and ziprasidone. That may precipitate cardiac arrest and arrhythmias. By contrast, lurasidone and aripiprazole carry a comparatively low risk of QTc prolongation.

PTCB tip: When a patient report or lab result lines up with a known risk for these drugs - a low ANC on clozapine, an out-of-range lithium level, or a dementia diagnosis on an atypical antipsychotic - a pharmacy technician’s job is to flag it for the pharmacist’s review, not to counsel the patient or decide whether to override a safety alert.

Antiepileptics (AEDs/Anticonvulsants)

  • Treat epilepsy (focal/generalized seizures) via sodium channels, GABA-chloride channels, calcium channels, sometimes glutamate; most hit multiple targets
  • Strong sodium blockers: phenytoin, topiramate, zonisamide, valproic acid, lamotrigine, carbamazepine; clonazepam (GABA); ethosuximide (calcium)
  • Gabapentin, pregabalin, carbamazepine also treat neuropathic pain
  • Common effects: drowsiness, rash, GI upset, menstrual/sexual dysfunction, teratogenicity, cognitive issues, suicidal ideation, blood dyscrasias
  • Weight gain: valproic acid, gabapentin, carbamazepine, pregabalin; Weight loss: topiramate, zonisamide, felbamate
  • Specific risks: phenytoin (gum hyperplasia, hirsutism), valproate (highest teratogenicity, liver dysfunction), vigabatrin (vision loss), lamotrigine/carbamazepine (Stevens-Johnson), carbamazepine/phenytoin/barbiturates (vitamin D deficiency, dyslipidemia), felbamate (liver dysfunction)

Lithium

  • Mood stabilizer for bipolar disorder/mania and some schizophrenia; balances GABA/dopamine, reduces oxidative stress, inhibits GSK
  • Effects: tremor, bloating, weight changes, rash, hair loss
  • Toxicity: mild (nausea, vomiting, diarrhea, coarse tremor) vs. severe (confusion, ataxia, slurred speech, seizures, coma)
  • Chronic risk: nephrogenic diabetes insipidus, thyroid dysfunction
  • Narrow therapeutic index — requires regular blood level monitoring

Antipsychotics — Typical vs. Atypical

  • Typical (1st-gen): strong D2 blockers (haloperidol, chlorpromazine, fluphenazine); treat positive symptoms only; long-acting IM forms (haloperidol, fluphenazine) aid compliance
  • Typical effects: sedation, dry mouth, hypotension, movement disorders (dystonia, akathisia, tardive dyskinesia), elevated prolactin; thioridazine (retinal deposits), chlorpromazine (corneal deposits)
  • Atypical (2nd-gen): weaker D2 + 5HT2A blockers; treat positive and negative symptoms; lower extrapyramidal risk, higher metabolic syndrome risk, higher mortality in elderly dementia patients
  • Clozapine: highly effective but risks agranulocytosis (ANC monitoring required), plus sedation, hypotension, tachycardia, weight gain
  • Long-acting injectables: aripiprazole, olanzapine, risperidone
  • Monitor glucose/lipids across atypicals due to metabolic risk

Next-Generation Antipsychotics & Cardiac Risk

  • Xanomeline/trospium (COBENFY, 2024): modulates muscarinic receptors instead of dopamine; xanomeline stimulates brain M1/M4, trospium limits peripheral side effects
  • Effects: urinary retention, liver dysfunction, glaucoma, angioedema, tachycardia, constipation, hypertension
  • QTc-prolonging risk: thioridazine, haloperidol, olanzapine, risperidone, ziprasidone; lower risk: lurasidone, aripiprazole
  • PTCB tip: Technicians flag abnormal labs/risk indicators (low ANC, abnormal lithium level, atypical antipsychotic in dementia) for pharmacist review — not counsel or override decisions

Sign up for free to take 32 quiz questions on this topic

Previous
Next  | 1.5.7.7 Anxiolytics, sedatives, and hypnotics
All rights reserved ©2016 - 2026 Achievable, Inc.

Antiepileptics, antipsychotics, and lithium

Antiepileptics

Antiepileptics are drugs used to prevent and treat seizures by reducing abnormal electrical activity in the brain. You may also see them called anticonvulsants or AEDs.

Epilepsy is a chronic disorder marked by recurring seizures. A seizure happens when electrical activity in the brain becomes dysregulated. This abnormal activity can be:

  • Localized (focal)
  • Generalized

AEDs help regulate and stop disorderly electrical activity by acting on ion channels, including:

  • Sodium channels
  • GABA-mediated chloride channels
  • Calcium channels

Some AEDs also block glutamate-mediated electrical currents. Most AEDs affect more than one target.

Several AEDs are strong sodium channel blockers, including:

  • Phenytoin
  • Topiramate
  • Zonisamide
  • Valproic acid
  • Lamotrigine
  • Carbamazepine

Some benzodiazepines (for example, clonazepam) have strong GABA-related activity. Ethosuximide primarily blocks calcium channels.

Some antiepileptics (such as gabapentin, pregabalin, and carbamazepine) are also used to treat neuropathic pain.

Commonly prescribed antiepileptics and their brand names are listed below:

  • Carbamazepine - Tegretol, Epitol
  • Levetiracetam - Keppra, Roweepra
  • Lamotrigine - Lamictal
  • Ethosuximide - Zarontin
  • Phenytoin - Dilantin, Phenytek
  • Fosphenytoin - Cerebyx
  • Felbamate - Felbatol
  • Topiramate - Topamax, Topiragen
  • Valproate or valproic acid or divalproex sodium - Depakote, Depakene, Stavzor, Depacon
  • Gabapentin - Gralise, Horizant, Neurontin
  • Pregabalin - Lyrica
  • Vigabatrin - Sabril
  • Tiagabine - Gabitril
  • Clonazepam - Klonopin
  • Oxcarbazepine - Trileptal
  • Zonisamide - Zonegran
  • Primidone - Mysoline
  • Lacosamide - Vimpat

Antiepileptics are frequently associated with adverse effects, which can make long-term adherence difficult. Common adverse effects include:

  • Drowsiness
  • Rash
  • Diarrhea
  • Disruption of menstrual cycles
  • Infertility
  • Sexual dysfunction
  • Teratogenicity
  • Cognitive issues
  • Restlessness

Weight effects vary by drug:

  • Weight gain: valproic acid, gabapentin, carbamazepine, pregabalin
  • Weight loss: topiramate, zonisamide, felbamate

Other important risks include increased suicidal tendencies, changes in blood counts, and severe allergic reactions.

Notable drug-specific adverse effects include:

  • Phenytoin: gum hyperplasia (overgrowth) and hirsutism
  • Valproate: highest risk of congenital defects in newborn children
  • Vigabatrin: vision problems
  • Lamotrigine (and carbamazepine): serious skin rashes, including Stevens-Johnson syndrome
  • Carbamazepine, phenytoin, and barbiturates: metabolic disturbances such as vitamin D deficiency and dyslipidemias
  • Felbamate and valproate: liver dysfunction

Lithium

Lithium is sold as generic lithium carbonate and under the brand name Lithobid. It is used to treat bipolar disorder and some cases of schizophrenia.

Bipolar disorder is a mood disorder characterized by episodes of mania followed by episodes of depression. Lithium is a mood stabilizer that can help control manic symptoms.

Lithium’s exact mechanism isn’t fully understood, but it’s thought to balance neurotransmitters such as GABA and dopamine, reduce oxidative stress, and inhibit the enzyme glycogen synthase kinase, producing an overall neuroprotective effect.

Adverse effects include restlessness, tremors, bloating, weight changes, rash, and hair loss.

Lithium excess can cause toxicity. Early or mild toxicity may include:

  • Nausea and vomiting
  • Diarrhea
  • Abdominal pain
  • Coarse tremor

Severe toxicity may include:

  • Confusion or delirium
  • Imbalance (ataxia)
  • Slurred speech
  • Seizures
  • Coma

Chronic toxicity may cause kidney damage called nephrogenic diabetes insipidus, which can lead to excessive urination, thirst, and dehydration. Lithium may also cause thyroid dysfunction.

Lithium has a narrow therapeutic index, so blood levels must be monitored regularly.

Antipsychotics

Antipsychotics are medications used to treat psychosis, which can occur in disorders such as schizophrenia, bipolar disorder (mania), and drug-induced psychosis. Many atypical antipsychotics are also approved specifically for treating bipolar disorder.

Based on their activity at neurotransmitter receptors, antipsychotics are classified as:

  • Typical (first-generation)
  • Atypical (second-generation)

Atypical antipsychotics have a lower risk of movement disorders and better effect on negative symptoms, but carry a higher risk of metabolic syndrome.

Typical or conventional or first-generation antipsychotics: These drugs act primarily by blocking D2 dopamine receptors. They include chlorpromazine, thioridazine (Mellaril), trifluoperazine, haloperidol (Haldol), fluphenazine, loxapine (Adasuve), prochlorperazine (Compro), molindone, perphenazine, thiothixene and pimozide (Orap).

Long-acting intramuscular (decanoate) formulations are available for haloperidol and fluphenazine. Long-acting forms are especially useful when compliance is a problem.

Typical antipsychotics can control positive symptoms of schizophrenia but are not useful for treating negative symptoms.

  • Positive symptoms: hallucinations, delusions, paranoia, etc.
  • Negative symptoms: lack of emotions, decreased speech, decreased drive, etc.

Adverse effects of typical antipsychotics include sedation, dry mouth, constipation, low blood pressure, cognitive defects, dystonia, muscle stiffness, tremors, galactorrhea and elevated prolactin levels, seizures, movement disorders, and metabolic syndrome (less likely).

Some drugs have notable eye-related effects:

  • Thioridazine may cause retinal deposits
  • Chlorpromazine may cause corneal deposits

Movement disorders can be incapacitating and may lead to drug non-compliance. These include acute dystonia, akinesia, bradykinesia, akathisia, and tardive dyskinesia.

Atypical or second-generation antipsychotics: These drugs act as weaker D2 blockers than typical antipsychotics, while also blocking serotonin 5HT2A receptors. They are effective in treating both positive and negative symptoms of schizophrenia.

They include clozapine (Clozaril, Versacloz), olanzapine (Zyprexa, Symbyax, Lybalvi), aripiprazole (Abilify, Aristada), asenapine (Saphris, Secuado), brexpiprazole (Rexulti), cariprazine (Vraylar), ziprasidone (Geodon), risperidone (Perseris, Risperdal), lurasidone (Latuda), quetiapine (Seroquel) etc.

Second-generation drugs are preferred because they have a low risk of extrapyramidal effects (movement disorders). However, they are associated with higher mortality in older patients with dementia.

Key points about specific agents:

  • Clozapine is notable for high efficacy.
  • Aripiprazole, olanzapine, and risperidone are available in long-acting injectable formulations.

Adverse effects of clozapine include sedation, hypotension, tachycardia, weight gain, metabolic syndrome, glucose intolerance, and rare but potentially fatal agranulocytosis. Agranulocytosis is severe neutropenia. The absolute neutrophil count (ANC) is monitored regularly during clozapine therapy.

Major adverse effects of second-generation drugs include metabolic syndrome, weight gain, and dyslipidemias. Blood glucose and lipid levels should be monitored.

Next-generation antipsychotics: Xanomeline and trospium combination sold as COBENFY were FDA-approved in 2024. Rather than blocking dopamine receptors, they work by modulating muscarinic (M) receptors in the brain: xanomeline stimulates muscarinic (M1/M4) receptors in the brain, while trospium blocks muscarinic receptors outside the brain to limit side effects such as nausea.

Adverse effects include urinary retention, liver dysfunction, jaundice, glaucoma, angioedema, fast heart rate, constipation, nausea, dizziness, and hypertension.

Antipsychotics that may prolong QTc: They include thioridazine, haloperidol, olanzapine, risperidone, and ziprasidone. That may precipitate cardiac arrest and arrhythmias. By contrast, lurasidone and aripiprazole carry a comparatively low risk of QTc prolongation.

PTCB tip: When a patient report or lab result lines up with a known risk for these drugs - a low ANC on clozapine, an out-of-range lithium level, or a dementia diagnosis on an atypical antipsychotic - a pharmacy technician’s job is to flag it for the pharmacist’s review, not to counsel the patient or decide whether to override a safety alert.

Key points

Antiepileptics (AEDs/Anticonvulsants)

  • Treat epilepsy (focal/generalized seizures) via sodium channels, GABA-chloride channels, calcium channels, sometimes glutamate; most hit multiple targets
  • Strong sodium blockers: phenytoin, topiramate, zonisamide, valproic acid, lamotrigine, carbamazepine; clonazepam (GABA); ethosuximide (calcium)
  • Gabapentin, pregabalin, carbamazepine also treat neuropathic pain
  • Common effects: drowsiness, rash, GI upset, menstrual/sexual dysfunction, teratogenicity, cognitive issues, suicidal ideation, blood dyscrasias
  • Weight gain: valproic acid, gabapentin, carbamazepine, pregabalin; Weight loss: topiramate, zonisamide, felbamate
  • Specific risks: phenytoin (gum hyperplasia, hirsutism), valproate (highest teratogenicity, liver dysfunction), vigabatrin (vision loss), lamotrigine/carbamazepine (Stevens-Johnson), carbamazepine/phenytoin/barbiturates (vitamin D deficiency, dyslipidemia), felbamate (liver dysfunction)

Lithium

  • Mood stabilizer for bipolar disorder/mania and some schizophrenia; balances GABA/dopamine, reduces oxidative stress, inhibits GSK
  • Effects: tremor, bloating, weight changes, rash, hair loss
  • Toxicity: mild (nausea, vomiting, diarrhea, coarse tremor) vs. severe (confusion, ataxia, slurred speech, seizures, coma)
  • Chronic risk: nephrogenic diabetes insipidus, thyroid dysfunction
  • Narrow therapeutic index — requires regular blood level monitoring

Antipsychotics — Typical vs. Atypical

  • Typical (1st-gen): strong D2 blockers (haloperidol, chlorpromazine, fluphenazine); treat positive symptoms only; long-acting IM forms (haloperidol, fluphenazine) aid compliance
  • Typical effects: sedation, dry mouth, hypotension, movement disorders (dystonia, akathisia, tardive dyskinesia), elevated prolactin; thioridazine (retinal deposits), chlorpromazine (corneal deposits)
  • Atypical (2nd-gen): weaker D2 + 5HT2A blockers; treat positive and negative symptoms; lower extrapyramidal risk, higher metabolic syndrome risk, higher mortality in elderly dementia patients
  • Clozapine: highly effective but risks agranulocytosis (ANC monitoring required), plus sedation, hypotension, tachycardia, weight gain
  • Long-acting injectables: aripiprazole, olanzapine, risperidone
  • Monitor glucose/lipids across atypicals due to metabolic risk

Next-Generation Antipsychotics & Cardiac Risk

  • Xanomeline/trospium (COBENFY, 2024): modulates muscarinic receptors instead of dopamine; xanomeline stimulates brain M1/M4, trospium limits peripheral side effects
  • Effects: urinary retention, liver dysfunction, glaucoma, angioedema, tachycardia, constipation, hypertension
  • QTc-prolonging risk: thioridazine, haloperidol, olanzapine, risperidone, ziprasidone; lower risk: lurasidone, aripiprazole
  • PTCB tip: Technicians flag abnormal labs/risk indicators (low ANC, abnormal lithium level, atypical antipsychotic in dementia) for pharmacist review — not counsel or override decisions

More from Drugs of the nervous system

  • Introduction to the nervous system and medications
  • Miscellaneous
  • Parkinson's disease
  • Treatment of ADHD
  • Analgesics and antidepressants